30.11-03.12.2021 Virtual ISPOR Europe 2021

30.11-03.12.2021 Virtual ISPOR Europe 2021

ISPOR 2020

COVID-19 Lockdown

» ϳ 1
» ϳ 2

.. : ϳ / ....- , , 2007.- 374 .̳

IV ( 15.06.2007 . 2 ).

ຠ , , . , 頠 ( ) 2004-2010 . ( ̳ 25.07.2003 . 1162) ' 2010 ( ̳ 13.06.2007 . 815). , 90- ', 蠠 , ﳿ . , . ( ) 2000-2002 ., , - . , .³ - , ᒺ . , , - . , , ̳ (ISPOR). , . , . . . . , , . і . , -, -, -, , - ̳- . , ﳿ.

, , -. , -, ﳿ. 15- (2007 ). , , , ,- . - , . , .ϳ , , , , , . -, - - , . , , 蠠 .

Բ79005 . ., 16 .(032) 297-14-27 ( )297-05-37www.afisha.lviv.ua

1.Zaliska O.N. The first steps of Pharmacoeconomics in Ukraine // ISPOR Fourth Annual European Congress.- Program.- Cannes, 2001.- France.- P.21.

2.Zaliska O. N. The cost-effectiveness analysis of celecoxib and NSAIDs with gastroprotective agents for treatment of rheumatoid artritis in Ukraine // Value in Health. Vol. 5, Issue 6. 2002. ISPOR 5thAnnual European Congress. Vol.5., N 6. P.475.

3.Zaliska O., Zhuravchak A. Costs and clinical consequences of alfuzosin and doxazozin in benigh prostatic hyperplasia in Ukraine // Value in Health ISPOR 8thInternational Meeting. Arlington,USA. 2003. P.22.

4.Zaliska O. Costs of pulmonary tuberculosis in Ukraine // Value in Health.-2003.-Vol. 6, Issue 6. Abstract 6thISPOR European Congress.Barselona, Spain.-P.756.

5.Zaliska O.,ParnovskyB.The current and future of pharmaco-economics in Ukraine // Value in Health.- 2005.- Vol. 8, Issue 3.- Abstract ISPOR 10thAnnual International Meeting, Washington, USA, May 15-18-.290.

6.Zaliska. Utworzenie Formulary Pa?stwowego na Ukrainie wed?ug wynik?w bada? farmakoekonomicznych // III Konferencja naukowa Polskiego Towarzystwa Farmakoekonomicznego.-Warshawa, 2005.- S. 11.

7.Zaliska., Pustak K. Badania farmakoekonomiczne preparatow antyconcepcejnych na Ukrainie // III Konferencja naukowa Polskiego Towarzystwa Farmakoekonomicznego.-Warshawa, 2005.- S. 12.

8.Zaliska.N., Boyko A.I. Theost of diabetes in Ukraine // Value in Health.- Value in Health Vol. 7, Issue 6. Abstracts ISPOR 7th Annual European Congress. Hamburg, Germany,2004.- P.736.

9.Zaliska., Parnovsky B. The use of pharmacoeconomics for creation of State Formulary in Ukraine // Value in Health.-Vol. 8, 6. Abstracts ISPOR 8thAnnual European Congress. Florencia, Italy. - 2005.- P.191.

10.Zaliska., Pushak K.I. A cost-effectiveness analysis of contraceptives in Ukraine // 2-ThISPOR Asia- Pacific Conference. Programm.- 2006 March Shanghai, PIH6. P.2.

11.Lendyak A. Theoretical and practical aspects of the retail Internet-Pharmacy // International medical students Congress.-Novi Sad.- 27-30 July, 2006.-Poster presentation.

12.Lendyak A. Internet-drugstores in Post USSR-countries Ukraine and Russia: problems and perspectives // 11-th World Congress on Internet in Medicine.- Toronto, Canada.- 16-17 October, 2006.

13.Lendyak A. Study of the expediency of implantation of National system of medical and pharmaceutical information via the Internet in Ukraine and Russia, which is made on the base of Ukrainian project Doctor.ua // MED-E-TEL..- Luxemburg.- 18-20 April, 2007.

14.Lendyak A. The Possibilities of using by post-USSR countries (Ukraine, Russia) the Internet-system of reporting about Adverse Drug Reactions.- PSWC 3-rd Pharmaceutical Sciences World Congress FIP.20-25 April 2007.

15. Lendyak A. National Drug of medical and pharmaceutical information in Ukraine, which is based on Internet-system // Healthdrug-2007 Conference.-Geneva, Sweycaria .- 25-27 October, 2007.

16.Lendyak A. Internet-systems of medical and pharmaceutical information in Ukraine // EFMI Special topic Conference: Medical information in enlarged Europe.-Brion land, Horvatia.- 30 May-1 June 2007.

17.Lendyak A. National Internet-system of medical and pharmaceutical information in Post USSR-countries // Cybertherapy-2007.Washington, USA.- 12-14 June 2007.

18.Zaliska O., Pushak K.I.Pharmacoeconomic analysis of oral and transdermal contraceptives in Ukraine// Value in Health. 2008.-Vol. 11, Issue 3. Abstracts ISPOR 13thISPOR Meeting. Toronto, Canada.-A.247-248.

19.Zaliska O., Maynych Yu. Pharmacoeconomic analysis of extemporal medicines used for treatment diseases at children in Ukraine//Value in Health.2009.Vol. 12, Issue 7. ISPOR Twelfth Annual European Congress, France, Paris, 2009.- P. 255.

20.Maynych Yu., Zalis'ka O. Personalized pharmacotherapy and analysis of extemporaneous dosage forms for children in Ukraine // Value of Health.-Vol.13, 7.-Abstracts 13thISPOR European Congress. -Prague, 2010- P.429.

21.Tolubaiev V., Zalis'ka O. ost analysis of bronchodilator prescriptions for treatment of stable COPD in Ukraine //Value in Health.- 2010.- Vol.13.- N. 7. -Abstracts 13thISPOR European Congress.- Prague,2010. P.320.

22.Zalis'ka O., Mandrik O.Pharmacoeconomics of innovative medicines for treatment of psoriasis in Ukraine //Value of Health.-2010.- Vol.13, 7.- P.400.

23.TolubaievV., Zalis'kaO., OstrovskyyM.,KorzhG.,Estimation ofdirect andinderectcosts of COPD in Ukraine:thepilotstudyresults//Value in Health.-2011.-Vol. 14, Issue 7.- Madrid, Spain.-A.491

24.HolovatyukI.,Zalis'kaO., TolubaievV.Evaluation of stable COPD medication costs in Ukraine based on GPS' prescriptions habits survey results//Value in Health.- 2011.-Vol.14, Issue 7.Madrid, Spain -A.492

25.Zaliska O., Maynych Y.Analysis of the formulary ensure children's hospitals in Ukraine: first results//Value in Health.-2011.-Vol. 14, Issue 7.Madrid, Spain. -A.407

26.Bocharova V., Zalis'ka O., Tolubaiev V., Majnych J. Comparative analysis of diseases prevalence rates in general ukrainian population and subpopulations of war veterans and Chernobyl victims//Value in Health.-2012.-Vol. 15, Issue 4.- Washington, USA.-A.27

27.Mandrik O., Severens J.L., Zalis'ka O., Doroshenko O. Analysis of factors influencing drugs prescription decision making in Ukraine//Value in Health.-2012.-Vol. 15, Issue 4,Washington, USA.-A.28

28.MandrikO., O. Zalis'kaO., Severens J.L.Cost-effectiveness analysis of rituximab use in treatment of chronic lymphocytic leukemia in Ukraine//Value in Health.- 2012.- Washington, USA. -Vol. 15, Issue 4.-A.221.

29.Tolubaiev V., Zalis'ka O., Mendrik O., Majnych J. Analysis of formulary lists for war veterans and Chernobyl victims in Ukraine//Value in Health.-2012.-Vol. 15, Issue 4.Washington, USA.- A.18.

30.MandrikO., O. Zalis'ka, J. Severens How Much price component is accounted for in State drugs purchase decisions in ukrainian oncology?//Value in Health.- 2012.-Vol. 15, Issue 7.- Berlin, Germany.-A.428.

31.TolubaievV, Zalis'kaO., KacherayJ.Socioeconomic burden of COPD in Ukraine: 2012-2020 perspective modeling//Value in.-Health.-2012.-Vol. 15, Issue 7.- Berlin, Germany.-A.562.

32.Kacheray Y., Zalis'ka O., Chavus H. Analysis of the Formulary Provision of Children in Ukraine//Value in Health.- 2012.-Vol. 15, Issue 7.-Berlin, Germany.-A.544.

33.Zaliska O., Tolubaiev V.,Kacheray J., Tolubaieva V. COPDprevalence and costs value in Ukraine//Value in Health2013.-Vol. 16, Issue 3.- New Orleans, USA. -A.233-234.

34.AntonchakZ., Zaliska O., Horbachevska O.-H Cost analysis of vaccination for children in Ukraine//Value in Health.- 2013.-Vol. 16, Issue 7.-Dublin, Ireland. -A.346.

35.TolubaievV., ZaliskaO., KacherayY.The List of medicines for COPD treatment in State formulary of Ukraine and related costs//Value in Health.-2013. -Vol. 16, Issue 7.- Dublin, Ireland -A.371.

36.Zaliska O., Maksymovych N., Zaliskyy O. Analysis of Adverse reactions of Medicine in Ukraine // Value in Health.- 2103.-Vol. 16,Issue 7.Dublin, Ireland-A.464.

37. Mandrik O.,Severens J-., Doroshenko O., Pankiv V., Kravchun M., Vlasenko N., Hulchiy M., Komisarenko Yu., Marsynyk E.,Sokolova L., ZaliskaO.,Mankovsky B.Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine //Journal of Multidisciplinary Health care.-2013.-6.- P.1-9.

38. Zaliska O., Slabyy M., Tolubaiev V., Revyatskyy I. Development of education on pharmacoeconomics in Ukraine // Journal of Health Policy &Outcomes Reseach.- 2013.-1.-.8-12.